Dr Reddys Laboratories

12.41 pm | 27 Dec 2018 |  Source: PTI

The newly launched product is in the strengths of 0.8 g and 2.4 g packets, and is a therapeutic equivalent generic version of Renvela (sevelamer carbo...

11.41 am | 24 Dec 2018 |  Source: PTI

The product is a therapeutic equivalent to generic version of Aggrenox (aspirin and extended-release dipyridamole) capsules, the company said in a BSE...

10.54 am | 30 Nov 2018 |  Source: Moneycontrol.com

We recommend traders to buy this stock in the range of Rs 2650 to 2625 with a price target of Rs 2900 and a stop loss placed below Rs 2520, says Adity...

11.19 am | 28 Nov 2018 |  Source: PTI

Dr Reddy's Laboratories Ltd launched Chlorthalidone tablets USP in the strengths of 25 mg and 50 mg, a therapeutic equivalent generic version of H...

8.57 am | 21 Nov 2018 |  Source: Moneycontrol.com

Dr Reddy's had booked sales of around $10-15 million days after its launch before it was stayed by the court....

2.52 pm | 12 Nov 2018 |  Source: PTI

"On November 9, 2018, the Regulatory Authority of Germany (Regierung von Oberbayem) concluded the follow-on audit of our formulations manufacturing fa...

5.14 pm | 09 Nov 2018 |  Source: Moneycontrol.com

To beat the pricing pressure and maintain profit margins, large generic drug makers have responded by slashing their generic pipelines and ANDA filing...

2.12 pm | 31 Oct 2018 |  Source: Moneycontrol.com

ICICI Direct is bullish on Dr Reddy’s Laboratories has recommended buy rating on the stock with a target price of Rs 2700 in its research report dat...

1.52 pm | 31 Oct 2018 |  Source: PTI

The Hyderabad-based company has received the approval from the US Food and Drug Administration (USFDA) to market its product which is a generic equiva...

9.57 pm | 30 Oct 2018 |  Source: PTI

As per the USFDA, a Form 483 is issued to a firm's management at the conclusion of an inspection when investigator has observed any conditions tha...

6.35 pm | 30 Oct 2018 |  Source: Moneycontrol.com

Moneycontrol reported in August that some drug makers are working towards producing APIs and key starting materials in house, while others have starte...

2.35 pm | 29 Oct 2018 |  Source: Moneycontrol.com

The pharma major reported a rise of 77 percent (year-on-year) in its net profit at Rs 503.8 crore. The company had reported a profit of Rs 284.9 crore...

9.17 pm | 26 Oct 2018 |  Source: Moneycontrol.com

“Looking ahead, our priority will be to resolve pending regulatory issues, and continue to work on execution and cost structures that will enable af...

3.37 pm | 26 Oct 2018

NULL...

3.17 pm | 26 Oct 2018 |  Source: Moneycontrol.com

The revenue rose to Rs 3,797.8 crore against Rs 3,546 crore that the company posted during the corresponding quarter of last year. This implies a rise...

9.12 am | 26 Oct 2018 |  Source: Moneycontrol.com

The effect of Suboxone based on US court order is likely to weigh as well....

3.41 pm | 24 Oct 2018 |  Source: Moneycontrol.com

A portion of complex abbreviated new drug applications is filed from this facility...

9.51 am | 19 Oct 2018 |  Source: Moneycontrol.com

The drug maker's partner Fresenius Kabi has completed clinical trial for Pegfilgrastim and announced that the drug has met primary end point in tw...

5.40 pm | 17 Oct 2018 |  Source: Moneycontrol.com

Net Sales are expected to increase by 10.8 percent Y-o-Y (up 5.6 percent Q-o-Q) to Rs. 3,930 crore, according to HDFC Securities....

11.23 am | 17 Oct 2018 |  Source: Moneycontrol.com

Net Sales are expected to increase by 5.3 percent Y-o-Y (up 0.4 percent Q-o-Q) to Rs. 3,750 crore, according to Sharekhan....